BoneAlbumin

About OrthoSera

OrthoSera is a Budapest-based regenerative medicine company pioneering the therapeutic use of blood serum and its components, particularly albumin, to activate stem cells and enhance tissue regeneration. Its lead product, BoneAlbumin—a serum albumin-enhanced bone allograft—has been in clinical use since 2015 with supporting long-term data. The company is developing a pipeline targeting osteoarthritis and skin rejuvenation while also applying its plasma expertise to areas like convalescent serum therapy. It maintains a fully integrated, quality-certified manufacturing and R&D operation.

Therapeutic Areas